<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present study tested the cytoprotective effect of <z:chebi fb="0" ids="4918">methyleugenol</z:chebi> in an in vivo <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> model (i.e. middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) for 1.5 h and subsequent reperfusion for 24 h) and further investigated its mechanism of action in in vitro cerebral ischemic models </plain></SENT>
<SENT sid="1" pm="."><plain>When applied shortly after reperfusion, <z:chebi fb="0" ids="4918">methyleugenol</z:chebi> largely reduced cerebral ischemic injury </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="4918">Methyleugenol</z:chebi> decreased the caspase-3 activation and <z:hpo ids='HP_0011420'>death</z:hpo> of cultured cerebral cortical neurons caused by oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation (OGD) for 1 h and subsequent re-oxygenation for 24 h </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="4918">Methyleugenol</z:chebi> markedly reduced <z:chebi fb="1" ids="18421">superoxide</z:chebi> generation in the ischemic brain and decreased the intracellular <z:mp ids='MP_0003674'>oxidative stress</z:mp> caused by OGD/re-oxygenation </plain></SENT>
<SENT sid="4" pm="."><plain>It was found that <z:chebi fb="0" ids="4918">methyleugenol</z:chebi> elevated the activities of <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase and catalase </plain></SENT>
<SENT sid="5" pm="."><plain>Further, <z:chebi fb="0" ids="4918">methyleugenol</z:chebi> inhibited the production of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> and decreased the protein expression of inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="4918">Methyleugenol</z:chebi> down-regulated the production of pro-inflammatory cytokines in the ischemic brain as well as in immunostimulated mixed glial cells </plain></SENT>
<SENT sid="7" pm="."><plain>The results indicate that <z:chebi fb="0" ids="4918">methyleugenol</z:chebi> could be useful for the treatment of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/<z:mp ids='MP_0001845'>inflammation</z:mp>-related diseases </plain></SENT>
</text></document>